AgomAb Therapeutics NV
AGMB----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBIT
TBA--
-0.02B--
----
EPS
TBA--
-0.388--
----
Upcoming earnings report - Q3 FY2026
Available dateNov 6, 2026
Estimate Revenue$0
Estimate EBIT--
Estimate EPS-$0.369
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly